Triple

T14008680
Position Surface form Disambiguated ID Type / Status
Subject Omicron variant E337019 entity
Predicate hasSublineage P77522 FINISHED
Object XBB.1.5
XBB.1.5 is a highly transmissible subvariant of SARS-CoV-2 that emerged from the Omicron lineage and became a dominant strain in several regions during the COVID-19 pandemic.
E1074418 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: XBB.1.5 | Statement: [Omicron variant, hasSublineage, XBB.1.5]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: XBB.1.5
Context triple: [Omicron variant, hasSublineage, XBB.1.5]
  • A. B.1.617.2
    B.1.617.2 is a highly transmissible SARS-CoV-2 variant of concern first identified in India and widely known for driving major global COVID-19 waves in 2021.
  • B. Omicron
    Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
  • C. Omicron variant
    The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
  • D. Delta variant
    The Delta variant is a highly transmissible strain of the SARS-CoV-2 virus that caused significant global surges in COVID-19 cases before the emergence of later variants.
  • E. BBIBP-CorV
    BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine produced by the Chinese state-owned pharmaceutical company Sinopharm.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: XBB.1.5
Triple: [Omicron variant, hasSublineage, XBB.1.5]
Generated description
XBB.1.5 is a highly transmissible subvariant of SARS-CoV-2 that emerged from the Omicron lineage and became a dominant strain in several regions during the COVID-19 pandemic.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: XBB.1.5
Target entity description: XBB.1.5 is a highly transmissible subvariant of SARS-CoV-2 that emerged from the Omicron lineage and became a dominant strain in several regions during the COVID-19 pandemic.
  • A. B.1.617.2
    B.1.617.2 is a highly transmissible SARS-CoV-2 variant of concern first identified in India and widely known for driving major global COVID-19 waves in 2021.
  • B. Omicron
    Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
  • C. Omicron variant
    The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
  • D. Delta variant
    The Delta variant is a highly transmissible strain of the SARS-CoV-2 virus that caused significant global surges in COVID-19 cases before the emergence of later variants.
  • E. BBIBP-CorV
    BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine produced by the Chinese state-owned pharmaceutical company Sinopharm.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c645c5c8190b1fd16a285a1b78a completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2ed44f90819099ad08c09c066b56 completed April 14, 2026, 12:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69fbaca5fb48819090fff1fd22e8a15c completed May 6, 2026, 9:03 p.m.
NEDg Description generation batch_69fbadc6cb2c8190bdf66ad1fa6dd392 completed May 6, 2026, 9:08 p.m.
NED2 Entity disambiguation (via description) batch_69fbb01071408190a85e5e9be0150593 completed May 6, 2026, 9:18 p.m.
Created at: April 9, 2026, 10:19 p.m.